Patent · US Active

Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof

US12030897B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Kevin X. Chen · Edison, US
Fen JIANG · Shanghai, CN
Xinde Chen · Shanghai, CN
Li Zhang · New Milford, US
Zhaoguo Chen · Shanghai, CN
Yanxin YU · Shanghai, CN
Kai ZHOU · Shanghai, CN
Boyu HU · Lianyungang, CN
Cheng Xie · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	May 8, 2019
Grant date	Jul 9, 2024
Priority date	—
Expiry date	Aug 26, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a group of pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and an application thereof in the preparation of a drug that serves as an HER2 inhibitor. Specifically, the present invention relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.